Recent News for SBPH - Spring Bank Pharmaceuticals, Inc.

Date Title
Oct 17 Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
Oct 8 VistaGen Therapeutics among healthcare gainers; Nektar Therapeutics and Puma Biotechnology among losers
Oct 7 Healthcare - Top 5 Gainers / Losers
Oct 1 We're Keeping An Eye On Spring Bank Pharmaceuticals's (NASDAQ:SBPH) Cash Burn Rate
Sep 27 The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep 26 The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
Sep 23 Spring Bank to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference in New York, NY
Sep 17 Yale Cancer Center to Present on the Synergistic Relationship Between Intravenously-Administered SB 11285, Spring Bank’s STING Agonist Development Compound, and Radiation Therapy in Cancer at the 2019 ASTRO Annual Meeting
Sep 4 Spring Bank Announces $20 Million Strategic Debt Financing Agreement with Pontifax Medison Finance
Aug 6 Spring Bank Announces Collaborative Research Agreement with University of Texas Southwestern Medical School for Evaluation of STING Antagonist Compounds
Jul 31 Spring Bank Pharma EPS beats by $0.28
Jul 31 Spring Bank Pharmaceuticals Reports Second Quarter 2019 Financial and Operational Results and Provides Business Development Update
Jul 29 Spring Bank Announces FDA Acceptance of IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
Jul 23 What Type Of Shareholder Owns Spring Bank Pharmaceuticals, Inc.'s (NASDAQ:SBPH)?
Jul 23 Spring Bank Announces Dosing of Inarigivir 400mg In Multiple HBV Studies
Jul 22 Spring Bank Pharmaceuticals, Inc. (SBPH) Shares March Higher, Can It Continue?
Jul 18 Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases to Evaluate HBV Antisense Oligonucleotide Compounds
Jul 15 AbbVie enters STING field with Mavupharma buy
Jul 10 Spring Bank Pharmaceuticals Announces Election of Pamela Klein, M.D., to its Board of Directors
Jul 5 48 Biggest Movers From Wednesday
Jul 3 NIO, SYMC and USNA among midday movers
Jul 1 Spring Bank Submits IND Application for SB 11285, an IV-Administered STING Agonist, for the Treatment of Advanced Solid Tumors
Jun 27 Spring Bank to Present Pre-Clinical Data on Its Novel STING Antagonist Program at The Autoimmunity Conference
Jun 27 The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO
Jun 25 The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
Back to the Main SBPH Page...